Airbnb, Disney+ et Microsoft : les dernières actualités

Microsoft’s CEO, Satya Nadella, has raised concerns about the impact of exclusive content deals on the competitive landscape of content acquisition for AI training, particularly highlighting Google’s deals with publishers.

Microsoft’s CEO raises concerns about exclusive content deals

During a landmark antitrust trial in the U.S., Satya Nadella, the CEO of Microsoft, expressed his concerns about the challenges posed by exclusive deals that tech giants, including Google, are securing with publishers. Nadella emphasized the importance of content acquisition for training artificial intelligence and highlighted the need for a fair and open competitive landscape.

AstraZeneca settles lawsuits related to heartburn treatments

AstraZeneca has agreed to pay $425 million to settle lawsuits in the U.S. related to its heartburn and stomach acid treatments, Nexium and Prilosec. These treatments have been the subject of litigation as some users claimed they caused kidney damage. The settlement aims to resolve the legal disputes surrounding the drugs.

Sanofi and Johnson & Johnson collaborate on E.coli vaccine

Sanofi has entered into a partnership with Janssen Pharmaceuticals, a unit of Johnson & Johnson, to develop and commercialize a vaccine candidate for extraintestinal pathogenic E. coli. The collaboration involves an upfront payment of $175 million from Sanofi to Janssen, as well as shared research and development costs. The vaccine is currently in late-stage clinical trials.

Takeda withdraws lung cancer drug from the U.S. market

Takeda Pharmaceutical has announced the voluntary withdrawal of its lung cancer drug, Exkivity (mobocertinib), from the U.S. market following a failed confirmatory trial. The company is also planning to initiate a similar withdrawal globally and is working with regulators in other countries where the drug is available to determine the next steps.

Target launches holiday toy shopping season with affordable options

Target has kicked off the holiday toy shopping season by offering a wide range of affordable toys and games, all priced under $25. The retailer has also unveiled its Bullseye’s Top Toys list, featuring trendy and popular toys, as well as exclusive collaborations to attract customers during the holiday season.

McCormick reports Q3 earnings

McCormick & Company has reported a 6% year-on-year sales growth for the third quarter of FY23, totaling $1.684 billion. The company’s adjusted EPS was in line with expectations. McCormick expects its revenue growth to be driven primarily by pricing actions and cost savings, which are anticipated to offset inflationary pressures.

ALX Oncology gains significant stock increase with interim gastric cancer data

ALX Oncology Holdings has released interim Phase 2 data from its ASPEN-06 trial, demonstrating a high overall response rate of 52% for its treatment of HER2-positive gastric/gastroesophageal junction cancer. The positive data has led to a significant increase in the company’s stock value.

Eli Lilly acquires POINT Biopharma for $1.4 billion

Eli Lilly and Company has announced the acquisition of POINT Biopharma Global for approximately $1.4 billion. The deal includes a cash payment of $12.50 per share, representing a premium to POINT’s stock price. The acquisition aligns with Eli Lilly’s focus on cancer treatments.

Disney+ tightens subscription sharing rules

Disney+ has informed its Canadian subscribers that it will be tightening its subscription sharing rules. Starting from November 1, subscribers will be prohibited from sharing their subscriptions outside of their household, unless permitted by their service tier. Violating these rules may result in limited or terminated access to the service.

Boeing aims for increased 737 production by mid-2025

Boeing is planning to elevate the production of its 737 narrowbody aircraft to unprecedented levels by mid-2025. This move reflects the surge in orders and the company’s rebound following the 737 MAX crisis. It is a continuation of Boeing’s earlier goal, which was disrupted in 2019 due to the grounding of the MAX fleet.

Novo Nordisk successfully defends patent claims

Novo Nordisk has successfully defended two pivotal patent claims related to its weight-loss and diabetes drugs, Wegovy and Ozempic. The company’s victory came in response to challenges initiated by Viatris, which aimed to pave the way for generic versions of the drugs. The ruling from the U.S. Patent Office tribunal protects Novo Nordisk’s intellectual property.

Japanese government provides subsidy to enhance Micron Technology’s factory

The Japanese government has granted a significant subsidy of ¥192 billion (approximately $1.3 billion) to Micron Technology to enhance its Hiroshima factory. The funds will be used to increase production of next-generation chips domestically, and Micron plans to incorporate advanced equipment from ASML Holding NV.

Airbnb faces challenges and proposes solutions

Airbnb is facing a tumultuous year marked by host unrest, competitive pressures, and regulatory challenges. The company’s CEO, Brian Chesky, has acknowledged these issues and proposed solutions to improve the platform and address host concerns. Airbnb is also navigating new regulations in cities like New York, which have posed significant challenges to its operations.

Delta uncovers unauthorized components in its jet engines

Delta Air Lines has discovered the presence of unauthorized components within some of its jet engines, joining other major U.S. airlines that have found fake parts in their machinery. While the nature of these components has not been disclosed, they represent a small percentage of Delta’s overall fleet.

Spotify CEO calls for AI regulation and criticizes tech giants

Spotify’s CEO, Daniel Ek, has expressed concerns about the rapid evolution of artificial intelligence and the dominance of tech giants like Apple and Google. Ek has called for a swift overhaul of AI regulations to keep up with the pace of technological advancements.

“Dumb Money” film explores the GameStop stock frenzy

The film “Dumb Money” delves into the GameStop stock frenzy that occurred in January 2021, portraying it as a classic underdog tale. However, a closer look reveals a more complex narrative, highlighting the financial losses that some retail investors experienced during the peak of the frenzy.

Source : www.nasdaq.com